Christoph U. Correll, MD
Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, New York; Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/ Northwell, Hempstead, New York; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany; German Center for Mental Health (DZPG), partner site Berlin, Berlin, Germany
Educational Activity
Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?
February 21, 2018
Long-acting injectable (LAI) antipsychotics have the potential to improve adherence and outcomes for patients with serious mental illness but are underused. Watch this Webcast to learn how to identify...
ASCP Corner
Nonpsychotic Psychiatric Disorders and Substance Use Disorders
April 26, 2017
This month's ASCP Corner discusses the significant problem of untreated psychiatric disorders and substance use disorders. The authors review the association between untreated illness and morbidity/mortality, look at ways...
